Marta Hermenegildo

  • Citations Per Year
Learn More
BACKGROUND The Escarval-Risk study aims to validate cardiovascular risk scales in patients with hypertension, diabetes or dyslipidemia living in the Valencia Community, a European Mediterranean region, based on data from an electronic health recording system comparing predicted events with observed during 5 years follow-up study. METHODS/DESIGN A cohort(More)
OBJECTIVE To evaluate the effect of dosage regimen (once-daily vs. twice-daily) of tobramicyn on steady-state serum concentrations and toxicity. MATERIALS AND METHODS Patients undergoing treatment with i.v. tobramycin (4 mg/kg/day) were randomised to two groups. Group OD (n = 22) received a once-daily dose of tobramycin and group TD (n = 21) received the(More)
s of Papers and Postezs Safe handling of medicines 22nd European Symposium on Clinical Pharmacy Heidelberg (Gezmany), 13-16 October i993 Organized by the European Society of Clinical Pharmacy Organizing Committee: Sabine Konder Hannelore Kreckel Evelyn Rehring Reinhild Rohde-BShler Reinhard Schierholz Hartmut Steckner Scientific Committee Rainer Brackertz(More)
  • 1